SEARCH

SEARCH BY CITATION

References

  • Barone F. C. and Feuerstein G. Z. (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819834.
  • Barr T. L., Latour L. L., Lee K. Y. et al. (2010) Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 41, e123e128.
  • de Belder A. J., MacAllister R., Radomski M. W., Moncada S. and Vallance P. J. (1994) Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc. Res. 28, 691694.
  • Berti R., Williams A. J., Moffett J. R., Hale S. L., Velarde L. C., Elliott P. J., Yao C., Dave J. R. and Tortella F. C. (2002) Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J. Cereb. Blood Flow Metab. 22, 10681079.
  • Chen H. Y., Chen T. Y., Lee M. Y., Chen S. T., Hsu Y. S., Kuo Y. L., Chang G. L., Wu T. S. and Lee E. J. (2006) Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J. Pineal Res. 41, 175182.
  • Chen H., Yoshioka H., Kim G. S. et al. (2011) Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid. Redox Signal. 14, 15051517.
  • Chou P. C., Shunmugavel A., Sayed H. E., Desouki M. M., Nguyen S. A., Khan M., Singh I. and Bilgen M. (2011) Preclinical use of longitudinal MRI for screening the efficacy of s-nitrosoglutathione in treating spinal cord injury. J. Magn. Reson. Imaging 33, 13011311.
  • Coert B. A., Anderson R. E. and Meyer F. B. (2003) Is neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH? Am. J. Physiol. Heart Circ. Physiol. 284, H151H159.
  • Colagiovanni D. B., Borkhataria D., Looker D., Schuler D., Bachmann C., Sagelsdorff P., Honarvar N. and Rosenthal G. J. (2011) Preclinical 28-day inhalation toxicity assessment of s-nitrosoglutathione in beagle dogs and wistar rats. Int. J. Toxicol. 30, 466477.
  • Erwin P. A., Lin A. J., Golan D. E. and Michel T. (2005) Receptor-regulated dynamic S-nitrosylation of endothelial nitric oxide synthase in vascular endothelial cells. J. Biol. Chem. 280, 1988819894.
  • Fortenberry J. D., Owens M. L., Chen N. X. and Brown L. A. (2001) S-nitrosoglutathione inhibits TNF-alpha-induced NFkappaB activation in neutrophils. Inflamm. Res. 50, 8995.
  • Foster M. W., Hess D. T. and Stamler J. S. (2009) Protein S-nitrosylation in health and disease: a current perspective. Trends Mol. Med. 15, 391404.
  • Gursoy-Ozdemir Y., Can A. and Dalkara T. (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35, 14491453.
  • Heiss C., Lauer T., Dejam A., Kleinbongard P., Hamada S., Rassaf T., Matern S., Feelisch M. and Kelm M. (2006) Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J. Am. Coll. Cardiol. 47, 573579.
  • Hoda N., Singh I., Singh A. K. and Khan M. (2009) Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. J. Neuroinflammation 6, 21.
  • Horstmann S., Kalb P., Koziol J., Gardner H. and Wagner S. (2003) Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34, 21652170.
  • Irmak M. K., Fadillioglu E., Sogut S., Erdogan H., Gulec M., Ozer M., Yagmurca M. and Gozukara M. E. (2003) Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem. Funct. 21, 283289.
  • Jatana M., Giri S., Ansari M. A., Elango C., Singh A. K., Singh I. and Khan M. (2006) Inhibition of NF-kB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J. Neuroinflammation 3, 12.
  • Jiang J., Wang W., Sun Y. J., Hu M., Li F. and Zhu D. Y. (2007) Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur. J. Pharmacol. 561, 5462.
  • Ju T. C., Chen S. D., Liu C. C. and Yang D. I. (2005) Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity. Free Radic. Biol. Med. 38, 938949.
  • Khan M., Sekhon B., Giri S., Jatana M., Gilg A. G., Ayasolla K., Elango C., Singh A. K. and Singh I. (2005) S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J. Cereb. Blood Flow Metab. 25, 177192.
  • Khan M., Jatana M., Elango C., Paintlia A. S., Singh A. K. and Singh I. (2006) Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15, 114124.
  • Khan M., Elango C., Ansari M. A., Singh I. and Singh A. K. (2007) Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J. Neurochem. 102, 365377.
  • Khan M., Im Y. B., Shunmugavel A., Gilg A. G., Dhindsa R. K., Singh A. K. and Singh I. (2009) Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J. Neuroinflammation 6, 32.
  • Khan M., Sakakima H., Dhammu T. S., Shunmugavel A., Im Y. B., Gilg A. G., Singh A. K. and Singh I. (2011) S-Nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J. Neuroinflammation 8, 78.
  • Kluge I., Gutteck-Amsler U., Zollinger M. and Do K. Q. (1997) S-Nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry. J. Neurochem. 69, 25992607.
  • Kuzkaya N., Weissmann N., Harrison D. G. and Dikalov S. (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 278, 2254622554.
  • Laursen J. B., Somers M., Kurz S., McCann L., Warnholtz A., Freeman B. A., Tarpey M., Fukai T. and Harrison D. G. (2001) Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103, 12821288.
  • Lima B., Lam G. K., Xie L. et al. (2009) Endogenous S-nitrosothiols protect against myocardial injury. Proc. Natl Acad. Sci. USA 106, 62976302.
  • Lo E. H., Dalkara T. and Moskowitz M. A. (2003) Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399415.
  • Lundblad C., Grande P. O. and Bentzer P. (2009) Hemodynamic and histological effects of traumatic brain injury in eNOS-deficient mice. J. Neurotrauma 26, 19531962.
  • Marshall H. E. and Stamler J. S. (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40, 16881693.
  • Matsuda F., Sakakima H. and Yoshida Y. (2011) The effects of early exercise on brain damage and recovery after focal cerebral infarction in rats. Acta Physiol. (Oxf) 201, 275287.
  • Molloy J., Martin J. F., Baskerville P. A., Fraser S. C. and Markus H. S. (1998) S-nitrosoglutathione reduces the rate of embolization in humans. Circulation 98, 13721375.
  • Moskowitz M. A., Lo E. H. and Iadecola C. (2010) The science of stroke: mechanisms in search of treatments. Neuron 67, 181198.
  • Pacher P., Beckman J. S. and Liaudet L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315424.
  • Parathath S. R., Parathath S. and Tsirka S. E. (2006) Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. J. Cell Sci. 119, 339349.
  • Parnham M. and Sies H. (2000) Ebselen: prospective therapy for cerebral ischaemia. Expert Opin. Investig. Drugs 9, 607619.
  • Phares T. W., Fabis M. J., Brimer C. M., Kean R. B. and Hooper D. C. (2007) A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J. Immunol. 178, 73347343.
  • Prasad R., Giri S., Nath N., Singh I. and Singh A. K. (2007) GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Glia 55, 6577.
  • Que L. G., Liu L., Yan Y., Whitehead G. S., Gavett S. H., Schwartz D. A. and Stamler J. S. (2005) Protection from experimental asthma by an endogenous bronchodilator. Science 308, 16181621.
  • Radomski M. W., Rees D. D., Dutra A. and Moncada S. (1992) S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol. 107, 745749.
  • Rashid P. A., Whitehurst A., Lawson N. and Bath P. M. (2003) Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome. J. Stroke Cerebrovasc. Dis. 12, 8287.
  • Rauhala P., Mohanakumar K. P., Sziraki I., Lin A. M. and Chiueh C. C. (1996) S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23, 5860.
  • Rauhala P., Lin A. M. and Chiueh C. C. (1998) Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12, 165173.
  • Ravi K., Brennan L. A., Levic S., Ross P. A. and Black S. M. (2004) S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc. Natl Acad. Sci. USA 101, 26192624.
  • Rosamond W., Flegal K., Furie K. et al. (2008) Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25e146.
  • Schonhoff C. M., Matsuoka M., Tummala H. et al. (2006) S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 103, 24042409.
  • Sharma S. S., Munusamy S., Thiyagarajan M. and Kaul C. L. (2004) Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia. J. Neurosurg. 101, 669675.
  • Shlosberg D., Benifla M., Kaufer D. and Friedman A. (2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393403.
  • Singh S. P., Wishnok J. S., Keshive M., Deen W. M. and Tannenbaum S. R. (1996) The chemistry of the S-nitrosoglutathione/glutathione system. Proc. Natl Acad. Sci. USA 93, 1442814433.
  • Singh I. N., Sullivan P. G. and Hall E. D. (2007) Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J. Neurosci. Res. 85, 22162223.
  • Stamler J. S., Toone E. J., Lipton S. A. and Sucher N. J. (1997) (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18, 691696.
  • Stanimirovic D. B., Wong J., Shapiro A. and Durkin J. P. (1997) Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults. Acta Neurochir. Suppl. 70, 1216.
  • Strbian D., Durukan A., Pitkonen M., Marinkovic I., Tatlisumak E., Pedrono E., Abo-Ramadan U. and Tatlisumak T. (2008) The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153, 175181.
  • Thiyagarajan M., Kaul C. L. and Sharma S. S. (2004) Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br. J. Pharmacol. 142, 899911.
  • Weissman D. E. and Stewart C. (1988) Experimental drug therapy of peritumoral brain edema. J. Neurooncol. 6, 339342.
  • Yemisci M., Gursoy-Ozdemir Y., Vural A., Can A., Topalkara K. and Dalkara T. (2009) Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat. Med. 15, 10311037.
  • Yu H., Wang P., An P. and Yixue X. (2012) Recombinant human angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VE-cadherin, and PKCalpha signaling after focal cerebral ischemia/reperfusion in rats. J. Mol. Neurosci. 46, 236247.
  • Zanini G. M., Martins Y. C., Cabrales P., Frangos J. A. and Carvalho L. J. (2012) S-nitrosoglutathione prevents experimental cerebral malaria. J. Neuroimmune Pharmacol. 7, 477487.
  • Zhang C. L., de la Lande I. S. and Horowitz J. D. (1995) Effects of glyceryl trinitrate tolerance on vascular responsiveness to constrictor agents in bovine isolated coronary artery. Clin. Exp. Pharmacol. Physiol. 22, 324329.